21 June 2022 | News
The Satellite Centre is the first Asia Pacific site in Johnson & Johnson's network of research collaborations aimed at addressing entrenched and emerging pandemic threats
Image credit: shutterstock
Johnson & Johnson (J&J) has announced the launch of the new J&J Satellite Centre for Global Health Discovery at Singapore's Duke-NUS Medical School, jointly established by Duke University and the National University of Singapore (NUS) as a graduate-entry medical school and research powerhouse.
As the first of the J&J Centere for Global Health Discovery in the Asia-Pacific (APAC) region, the Satellite Centre at Duke-NUS aims to help drive new solutions to address flaviviruses, which disproportionately impact communities across the region, by bringing together the talent and expertise of the world's largest healthcare company with that of a leading academic institution.
It builds on a longstanding collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Duke-NUS and marks the latest effort of the SingHealth Duke-NUS Academic Medical Centre to develop a collaborative Discovery District on its Campus to drive bench-to-bedside innovations. The collaboration will unite expertise from across the scientific community in the APAC region to further cultivate Singapore as a hub of discovery research, while advancing R&D to address the unmet medical need of flaviviruses.
Research at the Satellite Centre at Duke-NUS will be led by Professor Subhash Vasudevan, Ph.D., Duke-NUS' EID Program, and Olivia Goethals, Ph.D., Principal Scientist, Global Public Health R&D, Janssen Pharmaceutica NV.